Version 5.4
Mus musculus Protein: Rabepk
Summary
InnateDB Protein IDBP-538111.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Rabepk
Protein Name Rab9 effector protein with kelch motifs
Synonyms
Species Mus musculus
Ensembl Protein ENSMUSP00000122360
InnateDB Gene IDBG-163251 (Rabepk)
Protein Structure
UniProt Annotation
Function Rab9 effector required for endosome to trans-Golgi network (TGN) transport. {ECO:0000250}.
Subcellular Localization Cytoplasm {ECO:0000250}. Endosome membrane. Note=Interaction with PIP5K3 and subsequent phosphorylation recruits it to the endosomal membrane. {ECO:0000250}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 9 interaction(s) predicted by orthology.
Predicted by orthology
Total 9 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
Biological Process
Cellular Component
GO:0005886 plasma membrane
GO:0010008 endosome membrane
GO:0043231 intracellular membrane-bounded organelle
Protein Structure and Domains
PDB ID MGI:2139530
InterPro IPR006652 Kelch repeat type 1
IPR011498 Kelch repeat type 2
PFAM PF01344
PF07646
PRINTS
PIRSF
SMART SM00612
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q8VCH5
PhosphoSite PhosphoSite-Q8VCH5
TrEMBL B0R0S4
UniProt Splice Variant
Entrez Gene 227746
UniGene Mm.436837
RefSeq NP_663497
MGI ID
MGI Symbol Rabepk
OMIM
CCDS CCDS15951
HPRD
IMGT
EMBL AK035343 AL929106 BC019800
GenPept AAH19800 BAC29041 CAM24609

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca